Editorial office, European Journal of Clinical Oncology, UK
Perspective
Circular RNAs as Lung Cancer Biomarkers
Author(s): Angela Perez*
Lung cancer is the main cause of death and morbidity from malignant neoplasms globally, and patients bear a significant burden as a result of its poor prognosis. Smoking is linked to a high percentage of lung cancer cases. A considerable number of nonsmokers develop the disease, implying an epigenetic and genetic pathway for lung cancer development. The current state of lung cancer diagnosis and treatment is dire, and effective therapeutic targets and molecular markers are desperately needed. Circular RNAs (circRNAs) are non-coding RNAs that are covalently closed and have received a lot of attention because of their biological properties like conservatism, stability, and tissue specificity. Many studies have revealed that circRNAs have a key role in the early detection, therapy, and prognosis of lung cancer by regulating it through numerous mechanisms such as microRNA adsorption. Circ.. View More»
DOI:
10.35248/clinical-oncology. 4(4).46-47
